Although illegitimate V(D)J recombination may be responsible for creating CDKN2A deletions in acute lymphoblastic leukemia, more breakpoint sequence data will be needed for other types of cancers to delineate the molecular mechanisms [37], [38], [47], [48]. The gene discussed is CDKN2A; the disease is acute lymphoblastic leukemia.